Geratherm Medical AG

Share Issue/Capital Change • Mar 11, 2010

News Details

Ad-hoc | 11 March 2010 08:00

Geratherm Medical AG: Geratherm Medical AG opts to carry out capital increase of up to 10%

Geratherm Medical AG / Capital Increase

11.03.2010 08:00

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Ad-hoc release pursuant to section 15 of the Securities Trading Act (WpHG)

Capital increase

Geratherm Medical AG opts to carry out capital increase of up to 10%

Geschwenda, 11 March 2010 - The Managing Board of Geratherm Medical AG
(ISIN: DE0005495626) received Supervisory Board approval today to carry out
a capital increase of up to 10 % of the existing capital stock from
approved capital. This move excludes shareholders' subscription rights in
line with sec. 5 (5) of the Articles of Association. As part of a private
placement, up to 450,000 new shares with dividend rights from the fiscal
year 2009 onwards will be issued in return for cash contributions. This
would then increase the Company's capital stock by a possible EUR
450,000.00 from EUR 4,500,000.00 up to a potential EUR 4,950,000.00.

The new shares will be offered to qualified institutional investors both in
Germany and abroad as part of an accelerated book building process. The
capital increase is being supported by Close Brothers Seydler Bank AG,
Frankfurt am Main as sole lead manager und sole bookrunner.

The new shares are to be released for trading in the regulated market
(Prime Standard) of the Frankfurt Stock Exchange without prospectus.

The Managing Board

Short company profile:

Geratherm Medical is an internationally operating medical products
enterprise with the busi-ness areas 'Temperature Management', 'Cardio' and
'Respiratory'. Our company's roots are in temperature measurement in the
medical sphere. In this business area we offer a broad spectrum of
products, most of which have unique selling points. We supply our
custo-mers/patients with high-quality products ranging from thermometers to
complex warming sys-tems for use in the operating theatre and by emergency
rescue services. In the Cardio busi-ness area we concentrate on the
development of products for the detection of atrial fibrillation as a
measure to prevent strokes. The Respiratory segment develops and markets
products for the assessment of pulmonary function.

In all three business areas, Geratherm has patent-protected basic
technologies at its dispo-sal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the Ger-man Entrepreneurial Index and in the German
Health-Care Index.

Company contact:

Geratherm Medical AG

Investor Relations

Fahrenheitstraße 1

98716 Geschwenda

Tel. +49 (0)36205/98 111

Email: info@geratherm.com

www.geratherm.com

ISIN: DE 000 549 562 6

Cusip number: 549 562

Segment: Frankfurter Wertpapierbörse/Geregelter Markt/Prime Standard

Trading place: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

DISCLAIMER:

THIS PUBLICATION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT IN-TENDED,
AND SHOULD NOT BE CONSTRUED, AS AN OFFER TO SELL OR A SOLICITA-TION OF AN
OFFER TO BUY OR SUBSCRIBE FOR ANY SECURITIES. NO OFFER OF SECURITIES OF
GERATHERM MEDICAL AG, GESCHWENDA IS BEING, OR WILL BE, MADE IN ANY
JURISDICTION.

THIS PUBLICATION AND THE INFORMATION CONTAINED HEREIN IS NOT FOR
PUBLI-CATION OR DISTRI-BUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE
UNITED STATES, CANADA, AUSTRALIA OR JAPAN.

THE SECURITIES OF THE COMPANY DESCRIBED HEREIN HAVE NOT BEEN AND WILL NOT
BE REGISTE-RED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE
'SECURITIES ACT'), OR THE LAWS OF ANY STATE, AND MAY NOT BE OFFERED OR SOLD
WITHIN THE UNITED STATES, EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIRE-MENTS OF THE
SECURITIES ACT AND APPLICABLE STATE LAWS. THERE WILL BE NO PUBLIC
OFFE-RING OF SECURITIES IN THE UNITED STATES.

11.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Hamburg, Stuttgart

End of News DGAP News-Service

---